On this site you can find recent news about Profil. You can read more about Profil and our work as clinical research organization. Furthermore, we will discuss interesting topics that are of high interest to pharmaceutical or technology companies innovating in the diabetes field.
For any questions or comments, please feel free to contact us using the contact button on the right.
October 13, 2020
Dear all, Greetings from Germany! I am happy to share with you the newest edition of "Profil World" - our newsletter filled with information about clinical research in diabetes and obesity. On-demand
September 21, 2020
Profil continues the successful series of scientific online seminars. On October 7th, 2020 at 4 PM CEST we will air our free online seminar. The session is presented by Dr. Lars Bochmann, Director
September 8, 2020
The euglycemic, hyperinsulinemic glucose clamp is the gold standard for the determination of pharmacokinetic and pharmacodynamic (PK/PD) effects of (new) anti-diabetic drugs, in particular insulins.
August 4, 2020
From Nektar’s award-winning technology to its later commercial failure as Pfizer’s Exubera®. Followed by new hopes for Mannkind’s Afrezza® that suffered more commercial disappointment [1,2,3,4]. The
July 14, 2020
Sodium/glucose cotransporter 2 (SGLT2) inhibitors have gained momentum in the last few years due to their therapeutic effectivity and the potential to reduce cardiovascular (CV) risks in type 2
June 23, 2020
From fitness trackers and health apps to sophisticated sensors and software that support clinical decision, wearables are reshaping the delivery of health care. The use of wearables allows patients
June 2, 2020
Dear all, Greetings from Germany! I am happy to share with you the newest edition of "Profil World" - our newsletter filled with information about clinical research in diabetes and obesity. Free
May 26, 2020
How machine learning methods are changing diabetes research and diabetes care When voice assistants tell us what the weather will be like, when self-driving cars steer through dense city traffic, or